In this video interview, Kyle McAllister, co-founder, CEO, Trially, shares real-world examples of AI transforming clinical ...

Despite reaching out into new territories, most trials rely heavily on traditional methods of patient recruitment, such as flyers, posters, radio and television ads, as well as counting on ...

The platform's patient-focused outreach is beneficial in navigating the complexities of evolving eligibility criteria for ...

Instead, identifying early-stage individuals necessitates biomarker-based screening, which adds layers of complexity to an ...

As social media permeates all aspects of healthcare, Sean Johnson explores what role it can play in supporting clinical trial recruitment. The biggest barrier for pharmaceutical companies to ...

In this video interview, Kyle McAllister, co-founder, CEO, Trially, explains how AI is stepping in to fill staffing gaps in ...

Smith joins Trially at a pivotal moment. As clinical research sites face mounting enrollment pressure and shrinking pipelines, Trially has emerged as a category-defining technology. In a landscape ...

Discover what clinical trials are, why they're vital for new treatments, and how you can participate in life-changing medical research.

Pfizer insists that the discontinuation of the Phase II study was due to recruitment difficulties and was not linked to ...

The ophthalmic drug development industry is undergoing significant transformation, marked by unprecedented advancements in ...

Create vital connections that move patients from the shadows of isolation into the heart of clinical innovation ...